Genopole strengthens its ties with the Research Triangle Park
From Monday March 20 to Thursday March 24, Genopole's Partnership & Business Development team visited the Research Triangle Park biopark in North Carolina to strengthen scientific and industrial collaborations.
19 April 2023
Read the articleEnalees – a new proteomics laboratory
On Thursday, 6 April, Enalees inaugurated their new proteomics development and production laboratory for the veterinary market.
10 April 2023
Read the articleLambe: Detecting coagulation biomarkers with a natural nanopore
The Lambe laboratory showed proof of concept for a coagulation biomarker detection technology based on a natural nanopore.
09 March 2023
Read the articleGenoscope: Biomanufacturing with bacteria
A team led by Andrew Tolonen has developed a method to optimize the genetic engineering of Clostridium genus bacteria for biotech applications
15 February 2023
Read the articleShining light on a key mechanism of Duchenne muscular dystrophy
A Genethon team has provided new insights on a complex genetic mechanism involved in mitochondrial dysfunction in Duchenne muscular dystrophy.
16 December 2022
Read the articleA trio of genome sites associated with arterial hypertension
Researchers from the CNRGH and PARCC have identified three loci associated with an increased risk of developing primary hyperaldosteronism, a leading cause of arterial hypertension.
12 December 2022
Read the articleThe story of the domestic donkey told by its genome
Genoscope participated in the sequencing of the DNA of 250 donkeys in a study revealing the domestication of this species highly contributive to human activities to this day.
14 November 2022
Read the articleGalaxy-SynBioCAD: accelerating the arrival of green chemistry
Conceived by the Genomics Metabolics Unit, Galaxy-SynBioCAD accelerates biological design and engineering for the production of next generation chemical compounds.
28 October 2022
Read the articleT-FITNESS: Toward empowering CAR-T therapies for solid tumors
The Genopole team SysFate is participating in the international project T-FITNESS. The project, selected by the European Innovation Council, aims to resolve the difficulty of T-cell exhaustion in CAR-T therapies for solid tumors.
13 September 2022
Read the articleToward the genomic selection of farmed insects
France is historically a land of livestock farming. Cows for meat or milk, sheep, pigs, fowl of all sorts; France rears them all. And insects! With its genomic selection project for Tenebrio molitor beetles, the Genopole company Ÿnsect and its biocluster partner, the sequencing center Genoscope, are making France a pioneer in insect farming.
11 July 2022
Read the articleA feat in the study of planktonic life
A Genoscope research team was part of a pioneering study in environmental genomics. The researchers were able to at least partially reconstitute the genomes of close to 700 eukaryote species.
09 June 2022
Read the articleA two-drug combination to treat limb-girdle muscular dystrophies and cystic fibrosis
The I-Stem and Genethon laboratories have identified a promising drug combination in the setting of three genetic diseases sharing similar molecular mechanisms.
17 May 2022
Read the articleAn artificial intelligence to diagnose and explain
The IBISC laboratory has conceived an architecturally-innovative neural network able to provide not only a diagnostic prediction but also a biological explanation.
05 April 2022
Read the articleNews from the human genome
The 1 April edition of Science announced the publication of the human genome with the previously-missing 8% now added to it. Comments from the Genopole Director of Research.
04 April 2022
Read the articleConsequences of phthalate exposure during pregnancy
Jörg Tost and his team of the National Center of Human Genomics Research (CNRGH; CEA) were part of a large collaborative study aimed at determining the genome-wide correlation between phthalate exposure during pregnancy and methylation of placental DNA.
15 March 2022
Read the article